513
Views
6
CrossRef citations to date
0
Altmetric
Review

Comparing available JAK inhibitors for treating patients with psoriasis

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 281-294 | Received 29 Sep 2021, Accepted 03 Feb 2022, Published online: 10 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sotirios G. Tsiogkas, Maria G. Grammatikopoulou, Katerina-Maria Kontouli, Ioanna Minopoulou, Dimitrios D. Goulis, Efterpi Zafiriou, Dimitrios P. Bogdanos & Aikaterini Patsatsi. (2023) Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis. Expert Review of Clinical Immunology 19:12, pages 1485-1498.
Read now

Articles from other publishers (5)

Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, Balakumar Chandrasekaran, Biswa Mohan Sahoo, Anandhalakshmi Subramanian, Neelaveni Thangavel, Afaf Aldahish, Kumarappan Chidambaram, M. Alagusundaram, Santosh Kumar & Palani Selvam. (2023) Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review. Frontiers in Pharmacology 14.
Crossref
Yanpeng Li, Haodong Cui, Shipeng Li, Xingyan Li, Hongtao Guo, Kutty Selva Nandakumar & Zhilei Li. (2023) Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions. International Immunopharmacology 114, pages 109585.
Crossref
Joseph Dodson & Peter A. Lio. (2022) Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases. Current Allergy and Asthma Reports 22:12, pages 183-193.
Crossref
Anja Saalbach & Manfred Kunz. (2022) Impact of Chronic Inflammation in Psoriasis on Bone Metabolism. Frontiers in Immunology 13.
Crossref
Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, Ahmed H. Abdelazeem & Ahmed M. Gouda. (2022) A Comprehensive Overview of Globally Approved JAK Inhibitors. Pharmaceutics 14:5, pages 1001.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.